NFKB1 and Alzheimer disease: When activation of the canonical NF-κB pathway in Prx1+ skin fibroblasts is blocked by deletion of the Ikkb gene, cutaneous manifestations of AD occur, leading simultaneously to an increase in CCL11 expression (Ko et al. 2022).